4Zinser GM, McEleney K, Welsh J. Characterization of mammary tumor cell lines from wild type and vitamin D3 receptor knockout mice[J]. Mol Cell Endocrinol, 2003,200 (1-2) : 67-80.
5Vanden Bemd G J, Chang GT. Vitamin D and vitamin D analogs in cancer treatment[J]. Curr Drug Targets, 2002,3 (1) : 85-94.
6Colston C, Han M. Implicated in the growth regulatory effects of vitamin D in breast cancer[J]. Endocrine Related Cancer, 2001 ,(9) : 45-59.
7Barbareschi M, Veronese S, Caffo O, et al. Bcl-2 and p53 expression in node negative breast carcinoma: a study with long terra follow up[J]. Hum Pathol, 1996,27: 1149-1155.
8Wang TTY, PhangJM. Effects of estrogen on apoptotic path waysin human breast cancer cell line MCF-7[J].Cancer Res, 1995,55:2487-2489.
6Zinser GM,Mcelenoy K,Welsh J.Characterization of mammary tumor cell lines form wild type and vitamin D3 receptor Knockout mice [ J ].Mol cell Endocrinol,2003;200(1-2):67 ～ 80
7Liu M,Lee M,Cohen M,et al.Transcriptional activation of the CDK inhibitor p21 by vitamin D leads to the induced differentiation of the my eliomon cytic cell line U-937 [J].Gen Develop,1996;10:142～453
8Schrader M,Kahlen JP,Carlberg C.Functional characterization of a novel type of 1.25-dihydroxyvitamin D3 response element identified in the mouse c-fos promoter [J].Biochem Biohys Res Commun,1997;230:646 ～ 651
9Haldars,Chintapalli J,Croce CM.Taxol induces bcl-2 phosphoryldtion and death of prostate cancer cells [J].Cancer Research,1996;56(6):1253 ～ 2
10De Luca LM.Retinoids and their receptors in differentiation,embryogenesis,and neoplasia[J].FASEB J,1991,5(14):2 924～2 933.
8Davis CD. Vitamin D and cancer: current dilemmas and future research needs. Am J Clin Nutr,2008 ,88 :565-569.
9Martin L,Harold L, Newmark D. Vitamin D,calcium and prevention of breast cancer:a review. Am Colle J Nutr, 1999,5:392-397.
10Barbaresehi M, Veronese S, Carlo O, et al. Bel-2 and p53 expression in node-negative breast carcinoma: a study with long-term follow-up. Hum Pathol, 1996,27 : 1149-1155.
